Literature DB >> 20638985

Characterization of the expression, localization, and secretion of PANDER in alpha-cells.

Jason R Carnegie1, Claudia E Robert-Cooperman, Jianmei Wu, Robert A Young, Bryan A Wolf, Brant R Burkhardt.   

Abstract

The novel islet-specific protein PANcreatic DERived Factor (PANDER; FAM3B) has been extensively characterized with respect to the beta-cell, and these studies suggest a potential function for PANDER in the regulation of glucose homeostasis. Little is known regarding PANDER in pancreatic -cells, which are critically involved in maintaining euglycemia. Here we present the first report elucidating the expression and regulation of PANDER within the alpha-cell. Pander mRNA and protein are detected in alpha-cells, with primary localization to a glucagon-negative granular cytosolic compartment. PANDER secretion from alpha-cells is nutritionally and hormonally regulated by l-arginine and insulin, demonstrating similarities and differences with glucagon. Signaling via the insulin receptor (IR) through the PI3K and Akt/PKB node is required for insulin-stimulated PANDER release. The separate localization of PANDER and glucagon is consistent with their differential regulation, and the effect of insulin suggests a paracrine/endocrine effect on PANDER release. This provides further insight into the potential glucose-regulatory role of PANDER. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638985      PMCID: PMC2908920          DOI: 10.1016/j.mce.2010.05.008

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  38 in total

1.  Secretion of the hyperglycemic-glycogenolytic factor in normal dogs.

Authors:  P P FOA; L SANTAMARIA; H R WEINSTEIN; S BERGER; J A SMITH
Journal:  Am J Physiol       Date:  1952-10

2.  Secretory granule-mediated co-secretion of L-glutamate and glucagon triggers glutamatergic signal transmission in islets of Langerhans.

Authors:  Mitsuko Hayashi; Hiroshi Yamada; Shunsuke Uehara; Riyo Morimoto; Akiko Muroyama; Shouki Yatsushiro; Jun Takeda; Akitsugu Yamamoto; Yoshinori Moriyama
Journal:  J Biol Chem       Date:  2002-10-31       Impact factor: 5.157

3.  A new in vitro model for the study of pancreatic A and B cells.

Authors:  D G Pipeleers; P A in't Veld; M Van de Winkel; E Maes; F C Schuit; W Gepts
Journal:  Endocrinology       Date:  1985-09       Impact factor: 4.736

Review 4.  Regulation of pancreatic insulin and glucagon secretion.

Authors:  J E Gerich; M A Charles; G M Grodsky
Journal:  Annu Rev Physiol       Date:  1976       Impact factor: 19.318

5.  Interplay of nutrients and hormones in the regulation of glucagon release.

Authors:  D G Pipeleers; F C Schuit; C F Van Schravendijk; M Van de Winkel
Journal:  Endocrinology       Date:  1985-09       Impact factor: 4.736

6.  Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus.

Authors:  G M Reaven; Y D Chen; A Golay; A L Swislocki; J B Jaspan
Journal:  J Clin Endocrinol Metab       Date:  1987-01       Impact factor: 5.958

7.  Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells.

Authors:  Xiaopei Cao; Zhiyong Gao; Claudia E Robert; Scott Greene; Gang Xu; Weizhen Xu; Ewan Bell; Don Campbell; Yuan Zhu; Robert Young; Matteo Trucco; James F Markmann; Ali Naji; Bryan A Wolf
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

8.  Fractionation of synaptophysin-containing vesicles from rat brain and cultured PC12 pheochromocytoma cells.

Authors:  B Wiedenmann; H Rehm; M Knierim; C M Becker
Journal:  FEBS Lett       Date:  1988-11-21       Impact factor: 4.124

9.  Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.

Authors:  A D Baron; L Schaeffer; P Shragg; O G Kolterman
Journal:  Diabetes       Date:  1987-03       Impact factor: 9.461

Review 10.  Synaptic-like microvesicles, synaptic vesicle counterparts in endocrine cells, are involved in a novel regulatory mechanism for the synthesis and secretion of hormones.

Authors:  Y Moriyama; M Hayashi; H Yamada; S Yatsushiro; S Ishio; A Yamamoto
Journal:  J Exp Biol       Date:  2000-01       Impact factor: 3.312

View more
  8 in total

1.  A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression.

Authors:  Zongmeng Li; Haiwei Mou; Ting Wang; Jing Xue; Bo Deng; Lihua Qian; Ye Zhou; Wanghua Gong; Ji Ming Wang; Guohao Wu; Cheng-Fu Zhou; Jing Fang; Yingying Le
Journal:  Cancer Lett       Date:  2012-10-08       Impact factor: 8.679

2.  PANDER KO mice on high-fat diet are glucose intolerant yet resistant to fasting hyperglycemia and hyperinsulinemia.

Authors:  Claudia E Robert-Cooperman; Camella G Wilson; Brant R Burkhardt
Journal:  FEBS Lett       Date:  2011-04-07       Impact factor: 4.124

Review 3.  PANcreatic-DERived factor: novel hormone PANDERing to glucose regulation.

Authors:  Camella G Wilson; Claudia E Robert-Cooperman; Brant R Burkhardt
Journal:  FEBS Lett       Date:  2011-06-12       Impact factor: 4.124

4.  Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in mice.

Authors:  Camella G Wilson; Michael Schupp; Brant R Burkhardt; Jianmei Wu; Robert A Young; Bryan A Wolf
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

5.  Cytokines in the Progression of Pancreatic β-Cell Dysfunction.

Authors:  Chunjiong Wang; Youfei Guan; Jichun Yang
Journal:  Int J Endocrinol       Date:  2010-11-14       Impact factor: 3.257

6.  Enhanced glucose tolerance in pancreatic-derived factor (PANDER) knockout C57BL/6 mice.

Authors:  Shari L Moak; Grace C Dougan; Catherine B MarElia; Whitney A Danse; Amanda M Fernandez; Melanie N Kuehl; Mark G Athanason; Brant R Burkhardt
Journal:  Dis Model Mech       Date:  2014-09-12       Impact factor: 5.758

7.  FAM3B (PANDER) functions as a co-activator of FOXO1 to promote gluconeogenesis in hepatocytes.

Authors:  Yujing Chi; Yuhong Meng; Junpei Wang; Weili Yang; Zhe Wu; Mei Li; Di Wang; Fangfang Gao; Bin Geng; Lu Tie; Weiping Zhang; Jichun Yang
Journal:  J Cell Mol Med       Date:  2018-11-28       Impact factor: 5.310

Review 8.  Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.

Authors:  Serena Bonomi; Stefania Gallo; Morena Catillo; Daniela Pignataro; Giuseppe Biamonti; Claudia Ghigna
Journal:  Int J Cell Biol       Date:  2013-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.